Introduce

Genetic testing for BRCA ½ mutations

For breast and ovarian cancer patients

For HBOC(hereditary breast and ovarian cancer syndrome) patients

For patients with family history or the age of breast cancer potentially

BRCAaccuTest™ & BRCAaccuTest™PLUS is a regent for producing libraries for
analyzing the BRCA ½ genes using the NGS (next-generation sequencing) method,
which analyzes genomic DNA derived from blood or FFPE tissues.

Working Process

Workflow

Specification

Introduce

Genetic testing for BRCA ½ mutations

For breast and ovarian cancer patients

For HBOC(hereditary breast and ovarian cancer syndrome) patients

For patients with family history or the age of breast cancer potentially

Working Process

Specification

Performance

Comparison of variants detection

13 clinical samples + 2 cell lines = 35 variants detected previously by Sanger sequencing, FISH, Real-time PCR, etc.

Concordance rate ≥ 99/9%

Introduce

Genetic variants screening for solid tumors

Lung

Gastric

Colon

Breast / Ovarian cancer

Melanoma, etc.

Working Process

Performance

Composed of most target genes in targeted cancer therapy
Obtain high coverage uniformity across all targets
More efficient detection og cancer-causing mutations

variants detection rate in blind test ≥ 99% :
clinical samples tested

High reproducibility and increased depth og coverage

Introduce

Human Leucocyte Antigen typing Kit

Tissue transplantation

Autoimmune disorders

Drug Hypersensitivity

Chronic inflammation, etc.

Working Process

Specification

Information

Introduce

Genetic Variants Screening for solid tumors diagnostics

NGeneBio’s ONCOaccuPanel™ is the next generation of sequencing (NGS) To establish diagnostic and treatment strategies and predict prognosis for patients with solid cancer. In vitro diagnostic medical device.
ONCOaccuPanel ™ is an Essential Gene for Health Notification by the Ministry of Health and Welfare It consists of 328 genes, including 14, that are specific to cancer patients in Korea. Analytical automation software is also provided for convenience in the field You can increase it.

Working Process

Specification

Performance

Sensitivity = (next231+sanger2)/(miseq 232+sanger2) TP/(TP+FN) = 233/234 = 99.57%

Speccificity = (next2890+sanger4)/(miseq 2896+sanger4) TP/(TP+FN) = 2894/2900 = 99.79%

Vision

Core Value

Business Area

Molecular Diagnostics

Hereditary breast cancer kit

Rare genetic disorder test

New born genetic disease test

Companion Diagnostics

Breast cancer kit

Lung cancer kit

Colorectal cancer kit

Bioinformatics

Clinical NGS analysis system

Clinical NGS analysis client tool

NGS based LIMS

Business Model

  • 1Distribution / Strategic Partnership
  • 2OEM / ODM Business
  • 3Business Development